Global Peripheral Vascular Thrombectomy Devices Market, By Product Type (Aspiration Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Mechanical Thrombectomy Devices, Others), Device Type (Angioplasty Balloons, Angioplasty Stents, Catheters, EVAR Stent Grafts, Inferior Vena Cava Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Devices), End Use (Hospitals, Clinics, Ambulatory Clinics and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Peripheral Vascular Thrombectomy Devices Market
Data Bridge Market Research analyses that the peripheral vascular thrombectomy devices market will exhibit a CAGR of around 6.51% for the forecast period of 2021-2028. Rising pervalance of cardiovascular diseases, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of peripheral vascular thrombectomy devices market. Therefore, the peripheral vascular thrombectomy devices market value, which was USD 499.73 million in 2020, will rocket up to USD 827.68 million by 2028.
Thrombectomy devices are the medical devices that are used to remove clots. Therefore, the peripheral vascular thrombectomy devices are the medical devices that are used to get rid of blood clots in the peripheral arteries and veins. The peripheral vascular thrombectomy devices regulate the smooth flow of blood and alleviate symptoms of cardiovascular and neurological diseases.
Upsurge in the prevalence of obese and overweight population globally is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with burgeoning among geriatric population is another market growth determinant. Rising research and development proficiencies to provide effective treatment, growing number of cardiovascular and neurological diseases and increasing personal disposable income will further generate lucrative market growth opportunities.
However, high costs associated with treatment will derail the market growth rate. Death of skilled medical professionals and unfavourable reimbursement scenario in the developing and underdeveloped economies will further pose challenges for the market. Also, stringent regulations on product approvals will also hamper the market growth rate.
This peripheral vascular thrombectomy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on peripheral vascular thrombectomy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Peripheral Vascular Thrombectomy Devices Market Scope and Market Size
The peripheral vascular thrombectomy devices market is segmented on the basis of product type, device type and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product type, peripheral vascular thrombectomy devices market is segmented into aspiration thrombectomy devices, ultrasonic thrombectomy devices, mechanical thrombectomy devices, and others.
The device type segment of the peripheral vascular thrombectomy devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices and other devices. Angioplasty balloons segment is sub-segmented into old/ normal balloons, drug-eluting balloons, cutting and scoring balloons. Angioplasty stents segment is sub-segmented into drug-eluting stents and bare-metal stents. Bare-metal stents segment is further bifurcated into self-expandable stents and balloon-expandable stents. Catheters segment is sub-segmented into angiography catheters, guiding catheters and IVUS/OCT catheters. EVAR stent grafts segment is sub-segmented into abdominal aortic aneurysm stent grafts and thoracic aortic aneurysm stent grafts. Inferior vena cava filters segment is sub-segmented into and retrievable filters and permanent filters. Plaque modification devices segment is sub-segmented into atherectomy devices and thrombectomy devices. Hemodynamic flow alteration devices segment is sub-segmented into embolic protection devices and chronic total occlusion devices. Other devices segment is sub-segmented into guide wires, vascular closure devices, introducer sheaths and balloon inflation devices.
The peripheral vascular thrombectomy devices market has also been segmented based on the end use into hospitals, clinics, ambulatory clinics, and others.
Peripheral Vascular Thrombectomy Devices Market Country Level Analysis
The peripheral vascular thrombectomy devices market is analysed and market size insights and trends are provided by country, product type, device type and end use as referenced above.
The countries covered in the peripheral vascular thrombectomy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the peripheral vascular thrombectomy devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies, growing diabetic population base and prevalence of patient specific health care systems. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growth and expansion of healthcare industry in this region, ever-rising geriatric population and growing prevalence of cardiovascular disorders.
The country section of the peripheral vascular thrombectomy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The peripheral vascular thrombectomy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for peripheral vascular thrombectomy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the peripheral vascular thrombectomy devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Peripheral Vascular Thrombectomy Devices Market Share Analysis
The peripheral vascular thrombectomy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to peripheral vascular thrombectomy devices market.
The major players covered in the peripheral vascular thrombectomy devices market report are Biosensors International Group, Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated., ORBUSNEICH MEDICAL., Merit Medical Systems, Getinge AB., JOTEC GmbH, Cook, Bolton Medical, Medtronic, Terumo Corporation, BD, B. Braun Melsungen AG, Cardinal Health., Abbott., Boston Scientific Corporation, Q3 Medical Devices Limited, Koninklijke Philips N.V. and Cardiovascular Systems, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-